Review Article
Volume 5 Issue 11 - 2020
Coronavirus (SARS-CoV-2): Molecular Mechanism of Coronavirus and Therapeutic Approaches (Stem Cell Therapy and Vaccine) for the Treatment of COVID-19
Lalit M Jeena1*, Dinesh Kumar2, Renu Tanwar1, Arpit Saxena3, Sabita Chourasia4 and Bhupender Patuna1
1Department of IVF and Reproductive Biology Centre, Maulana Azad Medical College, New Delhi, India
2Department of Anatomy, Maulana Azad Medical College, New Delhi, India
3Research and Development, Hester Biosciences Ltd, Ahmedabad, India
4Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
*Corresponding Author: Lalit M Jeena, Department of IVF and Reproductive Biology Centre, Maulana Azad Medical College, New Delhi, India.
Received: August 20, 2020; Published: October 31, 2020


Coronavirus or SARS-CoV-2 is the causative agent of the pandemic viral pneumonia disease COVID-19, identified in the late 2019. It is said to have originated in Wuhan, China and has now spread throughout the world and is a global pandemic. SARS-CoV-2 belongs to β-coronavirus family and has an identical genomic structure to bat coronavirus. SARS-CoV-2 mediates the entry in to host cell through host angiotensin-converting enzyme 2 (ACE 2). SARS-CoV-2 S protein has higher affinity to ACE2 receptor and mainly spreads the infection in the respiratory tract. The specific drugs/vaccine or any therapeutics approaches are required to prevent the current pandemic. Unfortunately, till date, there is no specific vaccine or therapeutic which is available to control the disease. Research efforts for development of COVID-19 pandemic are unprecedented in terms of promising time period. In this regard, we conducted a review on SARS-CoV-2 to cover the molecular mechanism to improve and increase understanding of the virus and therapeutic approaches such as vaccine and mesenchymal stem cell therapy (MSCs), which may provide the basis of future management of COVID-19.

Keywords: SARS-CoV-2; Angiotensin-Converting Enzyme 2 (ACE 2); Interferons and MSCs


  1. Lai CC., et al. “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges”. International Journal of Antimicrobial Agents 17 (2020): 105924.
  2. De Groot RJ., et al. “Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group”. Journal of Virology 14 (2013): 7790-7792.
  3. Tomasi D. “Coronavirus disease (COVID-19). A socio epidemiological analysis”. Bennington, VT: Vermont Academy of Arts and Sciences LV (2020).
  4. Shereen MA., et al. “COVID-19 infection: origin, transmission, and characteristics of human coronaviruses”. Journal of Advanced Research (2020).
  5. Shi Z and Hu Z. “A review of studies on animal reservoirs of the SARS coronavirus”. Virus Research1 (2008): 74-87.
  6. Zhiqi S., et al. “From SARS to MERS, Thrusting Coronaviruses into the Spotlight”. Viruses1 (2019): 59.
  7. Yadav PD., et al. “Full-genome sequences of the first two SARS-CoV-2 viruses from India”. Indian Journal of Medical Research2 (2020): 200.
  8. Wu A., et al. “Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China”. Cell Host and Microbe (2020).
  9. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China, 2019”. New England Journal of Medicine (2020).
  10. Johns Hopkins, University and Medicine. New cases of COVID-19 in world countries (2020).
  11. Updated WHO recommendations for international traffic in relation to COVID-19 outbreak (2020).
  12. Kampf G., et al. “Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents”. Journal of Hospital Infection (2020): 195-6701.
  13. Ozili PK and Arun T. “Spillover of COVID-19: impact on the Global Economy”. Available at SSRN (2020).
  14. Lai MM and Cavanagh D. “The molecular biology of coronaviruses”. Advances in Virus Research 48 (1997): 1-100.
  15. International Committee on Taxonomy of Viruses. ICTV Master Species List (2009).
  16. Saberi A., et al. “A planarian nidovirus expands the limits of RNA genome size”. PLOS Pathogens 11 (2018): e1007314.
  17. Fehr AR., et al. “Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology”. Springer Science and Business Media New York 1282 (2015): 1-23.
  18. ML Agostini., et al. “Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease”. MBio 9 (2018): e00221-e00218.
  19. McBride R., et al. “The coronavirus nucleocapsid is a multifunctional protein 6.8 (2014): 2991-3018.
  20. Geller C., et al. “Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies”. Viruses11 (2012): 3044-3068.
  21. Wrapp D., et al. “Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation”. Science 6483 (2020): 1260-1263.
  22. Hussain S., et al. “Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus”. Journal of Virology 9 (2005): 5288-5295.
  23. Masters PS. “The molecular biology of coronaviruses”. Advances in Virus Research 66 (2006): 193-292.
  24. Cinatl J., et al. “Treatment of SARS with human interferons”. Lancet9380 (2003): 293-294.
  25. Stockman LJ., et al. “SARS: systematic review of treatment effects”. PLOS Medicine 3 (2006): e343.
  26. Laude H., et al. “Porcine respiratory coronavirus: molecular features and virus-host interactions”. Veterinary Research 2 (1993): 125-150.
  27. Saif LJ. “Animal coronavirus vaccines: lessons for SARS”. Developmental Biology 119 (2004): 129-140.
  28. EMA clarifies use of chloroquine and hydroxychloroquine for COVID-19 (2020).
  29. Indian manufacturer shows high hopes of Covid-19 vaccine development (2020).
  30. Draft landscape of COVID-19 candidate vaccines (2020).
  31. Coronavirus life span on certain surfaces. New England journal of medicine, the lancet microbiology.
  32. Rothan HA and Byrareddy SN. “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak”. Journal of Autoimmunity (2020).
  33. Hoffmann M., et al. “SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor”. Cell (2020).
  34. Hamming I., et al. “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus”. A first step in understanding SARS pathogenesis 203.2 (2004): 631-637.
  35. AJ Brown., et al. “Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase”. Antiviral Research 169 (2019): 104541.
  36. Metcalfe SM. “Mesenchymal stem cells and management of COVID-19 pneumonia”. Medicine in Drug Discovery (2020).
  37. Chrzanowski Wojciech., et al. “Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections”. Frontiers in Bioengineering and Biotechnology 8 (2020): 2296-4185.
  38. Fatima F., et al. “Non-coding RNAs in mesenchymal stem cell-derived extracellular vesicles: deciphering regulatory roles in stem cell potency, inflammatory resolve, and tissue regeneration”. Frontiers in Genetics 8 (2017): 161.
  39. Chen J., et al. “Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment”. Engineering (2020).
  40. Curley GF., et al. “Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury”. Anesthesiology 118 (2013): 924-932.
  41. Wilson JG., et al. “Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial”. The Lancet Respiratory Medicine 3 (2015): 24-32.
  42. Fergie N., et al. “Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair”. The FASEB Journal 33 (2019): 5585-5598.
  43. Golchin A., et al. “The clinical trials of Mesenchymal stem cell therapy in skin diseases: An update and concise review”. Current Stem Cell Research and Therapy1 (2018): 22-33.
  44. Mehta P., et al. “Correspondence COVID-19: consider cytokine storm syndromes”. The Lancet20 (2020): 19-20.
  45. Weiss ARR and Dahlke MH. “Immunomodulation by Mesenchymal stem cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs”. Frontiers in Immunology 10 (2019): 1-10.
  46. Glenn JD and Whartenby K. “Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy”. World Journal of Stem Cells 5 (2014): 526-539.
  47. Leng Z., et al. “Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia”. Aging and Disease2 (2020): 216.
  48. Zhao K and Liu Q. “The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation”. Journal of Hematology and Oncology (2016).
  49. Novello S., et al. “Clinical application of mesenchymal stem cells in periodontal regeneration: A systematic review and meta-analysis”. Journal of Periodontal Research1 (2020): 1-12.
  50. Bing Liang., et al. “Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord”. China Xiv (2020).
Citation: Lalit M Jeena., et al. “Coronavirus (SARS-CoV-2): Molecular Mechanism of Coronavirus and Therapeutic Approaches (Stem Cell Therapy and Vaccine) for the Treatment of COVID-19”. EC Veterinary Science 5.11 (2020): 84-94.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 19, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.